Insider · CIK 0001857806
Juergen Eckhardt
Files at MGX (Metagenomi Therapeutics, Inc.). First filing -, latest -.
In brief
Juergen Eckhardt files SEC Form 4 as director at MGX (Metagenomi Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Juergen Eckhardt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | MGX Metagenomi Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,000 | $0.00 | $0 | 21,000 | Jun 11, 2026 |
| Jun 10, 2025 | MGX Metagenomi Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,000 | $0.00 | $0 | 21,000 | Jun 12, 2025 |
Questions about Juergen Eckhardt
Answered from the filings on this page, as of the latest one.
Is Juergen Eckhardt buying or selling?
Juergen Eckhardt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Juergen Eckhardt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Juergen Eckhardt has 0.
Where does Juergen Eckhardt file Form 4?
Juergen Eckhardt has filed Form 4 at MGX (Metagenomi Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.